Maryse Guérin
Inserm(FR)Sorbonne Université(FR)Sorbonne Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Pitié-Salpêtrière Hospital(FR)National Institute of Health(AM)Fondation pour l’innovation en Cadiométabolisme et Nutrition(FR)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Cholesterol and Lipid Metabolism, Cancer, Lipids, and Metabolism, Lipid metabolism and disorders
Most-Cited Works
- → Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors(2009)294 cited
- → Proatherogenic Role of Elevated CE Transfer From HDL to VLDL 1 and Dense LDL in Type 2 Diabetes(2001)260 cited
- → Action of Atorvastatin in Combined Hyperlipidemia(2000)235 cited
- → The intestinal microbiota regulates host cholesterol homeostasis(2019)205 cited
- → Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but ABCG1-Independent(2009)190 cited
- → Fenofibrate Reduces Plasma Cholesteryl Ester Transfer From HDL to VLDL and Normalizes the Atherogenic, Dense LDL Profile in Combined Hyperlipidemia(1996)189 cited